Merck's Ford-Hutchinson elected to Inovio SAB
This article was originally published in Scrip
Executive Summary
Dr Anthony Ford-Hutchinson has joined the scientific advisory board of vaccines company Inovio Pharmaceuticals. Dr Ford-Hutchinson has over 30 years' experience in vaccine development and commercialisation, and retired from Merck & Co last month having served as senior vice-president of vaccines research and development and chair of the board for MSD Wellcome Trust Hilleman Labs.